Literature DB >> 9345562

[Primary immunodeficiency in Tunisia: study of 152 cases].

M Bejaoui1, M R Barbouche, A Sassi, B Larguche, N Miladi, A Bouguerra, K Dellagi.   

Abstract

BACKGROUND: Primary immunodeficiencies are rare immunopathological disorders. A multidisciplinary study group was set up in Tunis in 1988 and has since identified 152 cases of such diseases. We herein present our series and compare it to the international registries. POPULATION AND METHODS: Over a period of 8 years (April 1988-April 1996), 295 children suffering from recurrent infections were investigated; primary immunodeficiency was confirmed in 152 out of them. The immunological investigation included a study of specific and/or non specific humoral and cellular immunity.
RESULTS: These 152 patients belonged to 129 families among which 70 were consanguine (54%). Familial primary immunodeficiency occurred in 23 of them. In 39 families (30%), one or more deaths occurred during early childhood. In more than half of the cases (89 cases), the immunological investigations revealed a cellular or combined immunodeficiency with a majority of ataxia-telangiectasia syndromes (53 cases), T cell activation immunodeficiencies (12 cases) and HLA class II deficiency (nine cases). A predominant antibody defect was observed in 35 patients with a majority of agammaglobulinemia (11 cases) and hyper-IgM syndromes (11 cases). A defect of non specific cellular immunity was found in 18 cases (11.8%) including seven cases of chronic granulomatous disease and five cases of leukocyte adhesion deficiency. Three children (1.9%) were deficient in the complement system. Deaths occurred so far in 37 patients (24.3%).
CONCLUSIONS: Primary immunodeficiencies are relatively frequent in Tunisia, probably because of the high rate of consanguinity among the general population. The distribution of the different groups of primary immunodeficiencies is characterized by high frequency of ataxia-telangiectasia and hyper-IgM syndrome and scarcity of severe combined immunodeficiencies and Wiskott-Aldrich syndrome.

Entities:  

Mesh:

Year:  1997        PMID: 9345562     DOI: 10.1016/s0929-693x(97)88145-6

Source DB:  PubMed          Journal:  Arch Pediatr        ISSN: 0929-693X            Impact factor:   1.180


  10 in total

1.  Population prevalence of diagnosed primary immunodeficiency diseases in the United States.

Authors:  J M Boyle; R H Buckley
Journal:  J Clin Immunol       Date:  2007-06-19       Impact factor: 8.317

2.  Novel mutation in the ATM gene in a Malian family with ataxia telangiectasia.

Authors:  Guida Landouré; Fanny Mochel; Katherine Meilleur; Madani Ly; Modibo Sangaré; Nouhoum Bocoum; Koumba Bagayoko; Thomas Coulibaly; Amadou M Sarr; Hamidou O Bâ; Souleymane Coulibaly; Cheick O Guinto; Mahamadou Touré; Moussa Traoré; Kenneth H Fischbeck
Journal:  J Neurol       Date:  2012-11-11       Impact factor: 4.849

3.  Community-acquired poliovirus infection in children with primary immunodeficiencies in Tunisia.

Authors:  Hinda Triki; Mohamed Ridha Barbouche; Olfa Bahri; Mohamed Bejaoui; Koussay Dellagi
Journal:  J Clin Microbiol       Date:  2003-03       Impact factor: 5.948

Review 4.  Report of the Tunisian Registry of Primary Immunodeficiencies: 25-Years of Experience (1988-2012).

Authors:  Fethi Mellouli; Imen Ben Mustapha; Monia Ben Khaled; Habib Besbes; Monia Ouederni; Najla Mekki; Meriem Ben Ali; Beya Larguèche; Mongia Hachicha; Tahar Sfar; Neji Gueddiche; Siheme Barsaoui; Azza Sammoud; Khadija Boussetta; Saida Ben Becher; Ahmed Meherzi; Najoua Guandoura; Lamia Boughammoura; Abdelaziz Harbi; Fethi Amri; Fethi Bayoudh; Najla Ben Jaballah; Neji Tebib; Asma Bouaziz; Abdelmajid Mahfoudh; Hajer Aloulou; Lamia Ben Mansour; Imen Chabchoub; Raoudha Boussoffara; Jalel Chemli; Jihène Bouguila; Saida Hassayoun; Saber Hammami; Zakia Habboul; Agnès Hamzaoui; Jamel Ammar; Mohamed-Ridha Barbouche; Mohamed Bejaoui
Journal:  J Clin Immunol       Date:  2015-10-13       Impact factor: 8.317

5.  First report on the Moroccan registry of primary immunodeficiencies: 15 years of experience (1998-2012).

Authors:  A A Bousfiha; L Jeddane; N El Hafidi; N Benajiba; N Rada; J El Bakkouri; A Kili; S Benmiloud; I Benhsaien; I Faiz; O Maataoui; Z Aadam; A Aglaguel; L Ait Baba; Z Jouhadi; R Abilkassem; M Bouskraoui; M Hida; J Najib; H Salih Alj; F Ailal
Journal:  J Clin Immunol       Date:  2014-03-12       Impact factor: 8.317

6.  Primary immunodeficiencies: a 27-year review at a tertiary paediatric hospital in Cape Town, South Africa.

Authors:  Reené Naidoo; Lisa Ungerer; Margaret Cooper; Sandra Pienaar; Brian S Eley
Journal:  J Clin Immunol       Date:  2010-09-22       Impact factor: 8.317

7.  The 752delG26 mutation in the RFXANK gene associated with major histocompatibility complex class II deficiency: evidence for a founder effect in the Moroccan population.

Authors:  Hamid Naamane; Ouafaa El Maataoui; Fatima Ailal; Abdelhamid Barakat; Siham Bennani; Jilali Najib; Mohammed Hassar; Rachid Saile; Ahmed Aziz Bousfiha
Journal:  Eur J Pediatr       Date:  2010-04-23       Impact factor: 3.183

8.  Primary immunodeficiency diseases in Egyptian children: a single-center study.

Authors:  Shereen M Reda; Hanaa M Afifi; Mai M Amine
Journal:  J Clin Immunol       Date:  2008-11-11       Impact factor: 8.317

9.  Primary immunodeficiency diseases in oman: five years' experience at sultan qaboos university hospital.

Authors:  Salem Al-Tamemi; Ibtisam Elnour; David Dennison
Journal:  World Allergy Organ J       Date:  2012-05-15       Impact factor: 4.084

10.  Clinical, immunological and genetic features in eleven Algerian patients with major histocompatibility complex class II expression deficiency.

Authors:  Réda Djidjik; Nesrine Messaoudani; Azzedine Tahiat; Yanis Meddour; Samia Chaib; Aziz Atek; Mohammed Elmokhtar Khiari; Nafissa Keltoum Benhalla; Leila Smati; Abdelatif Bensenouci; Mourad Baghriche; Mohammed Ghaffor
Journal:  Allergy Asthma Clin Immunol       Date:  2012-08-03       Impact factor: 3.406

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.